Regulation of cardiac allograft immune responses by microRNA-155
Transplant Immunology · 2024
DOI: 10.1016/j.trim.2024.102113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Immunology, 2024. Verfasst von Sandhya Bansal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States of America. Hauptthemen laut MEDLINE: MicroRNAs, Heart Transplantation, Graft Rejection, Mice, Knockout. Die Arbeit nennt 37 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIH.
Abstract (Originalsprache)
INTRODUCTION: A better understanding of the immune mechanisms involved in allograft rejection after transplantation is urgently needed to improve patient outcomes. As microRNA-155 (miR155) plays a critical role in inflammation, we postulated that a deficiency of miR155 will improve cardiac allograft survival and enhance tolerance induction after heart transplantation. METHODS: We developed an acute rejection mouse model through heterotopic BALB/c cardiac transplantation to C57BL/6 (wild-type) and C57BL/6 miR155 knock-out (miR155KO) mice. Further, we induced tolerance in both groups through a costimulatory blockade with CTLA4-Ig (200 μg; post-transplant day 2) and MRI antibodies (250 μg; post-transplant day 0), targeting CD28/B7 and CD40/CD154 signals, respectively. Finally, we examined the effects of injecting 100 μg of small extracellular vesicles (sEVs) isolated from wild-type mice undergoing rejection into tolerant miR155KO mice. RESULTS: Mean survival time (MST) of the cardiac allografts in wild-type and miR155KO mice was 7 and 15 days, respectively (p 100 days in the wild-type and miR155KO recipients, respectively (p 100 days; p < 0.0001). CONCLUSION: miR155KO mice have improved cardiac allograft survival and enhanced induction of tolerance after heterotopic cardiac transplantation. Injection of sEVs from wild-type mice undergoing rejection into the miR155KO mice reversed these benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States of America.
- Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States of America. Electronic address: tm.kumar@dignityhealth.org.
Förderung
- NHLBI NIH HHS
- NIH
Zitieren
APA
Bansal, S., Itabashi, Y., Guerrero-Alba, A., Fleming, T., Smith, M. A., Bremner, R. M., & Mohanakumar, T. (2024). Regulation of cardiac allograft immune responses by microRNA-155. Transplant Immunology. https://doi.org/10.1016/j.trim.2024.102113
Vancouver
Bansal S, Itabashi Y, Guerrero-Alba A, Fleming T, Smith MA, Bremner RM, et al. Regulation of cardiac allograft immune responses by microRNA-155. Transplant Immunology. 2024. doi:10.1016/j.trim.2024.102113
BibTeX
@article{Bansal2024,
author = {Bansal, Sandhya and Itabashi, Yoshihiro and Guerrero-Alba, Alexa and Fleming, Timothy and Smith, Michael A and Bremner, Ross M and Mohanakumar, T},
title = {Regulation of cardiac allograft immune responses by microRNA-155},
journal = {Transplant Immunology},
year = {2024},
doi = {10.1016/j.trim.2024.102113}
}
EUVIMED